Mesa Laboratories, Inc. MLAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 523.98% | 874.19% | 440.02% | 101.50% | 99.36% |
| Total Depreciation and Amortization | -8.58% | -8.23% | -5.12% | 7.26% | -7.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.46% | 54.37% | 2.79% | -95.51% | -93.06% |
| Change in Net Operating Assets | 944.67% | 930.61% | -172.23% | -86.66% | -107.10% |
| Cash from Operations | 26.01% | 46.67% | -8.50% | -11.68% | 1.18% |
| Capital Expenditure | 42.93% | 35.88% | 23.51% | 10.85% | 15.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 46.57% | 39.35% | 27.76% | -25.24% | 95.28% |
| Total Debt Issued | -90.70% | 919.05% | 46.33% | 46.33% | -25.59% |
| Total Debt Repaid | 61.35% | -244.29% | -15.92% | -25.72% | -26.91% |
| Issuance of Common Stock | -74.14% | -59.87% | -59.87% | 934.92% | 934.92% |
| Repurchase of Common Stock | -3.64% | -3.64% | -139.23% | -167.58% | -167.58% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.60% | -1.61% | -1.59% | -1.36% | -1.13% |
| Other Financing Activities | 97.00% | 89.25% | -2,227.65% | -598.21% | -466.36% |
| Cash from Financing | -13.01% | -0.94% | 5.97% | -2.52% | -243.18% |
| Foreign Exchange rate Adjustments | -57.98% | -84.34% | 43.84% | 12,342.86% | 27.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 148.28% | 230.91% | 55.99% | -172.51% | 65.29% |